logo
Book a meeting
Slayback Pharma

Slayback Pharma

Pharmaceuticals, 301 Carnegie CTR, Princeton, New Jersey, 08540, United States, 51-200 Employees

slayback-pharma.com

  • LinkedIn

phone no Phone Number: 60********

Who is SLAYBACK PHARMA

Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex...

Read More

lock icon Get Full Access
map
  • 301 Carnegie CTR, Princeton, New Jersey, 08540, United States Headquarters: 301 Carnegie CTR, Princeton, New Jersey, 08540, United States
  • 2011 Date Founded: 2011
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from SLAYBACK PHARMA

Slayback Pharma Org Chart and Mapping

Employees
Meredith Barak

Meredith Barak

Director, Sales and Marketing Operations

Pete Meyers

Pete Meyers

Chief Financial Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for Slayback Pharma
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Slayback Pharma

Answer: Slayback Pharma's headquarters are located at 301 Carnegie CTR, Princeton, New Jersey, 08540, United States

Answer: Slayback Pharma's phone number is 60********

Answer: Slayback Pharma's official website is https://slayback-pharma.com

Answer: Slayback Pharma's revenue is $25 Million to $50 Million

Answer: Slayback Pharma's SIC: 2834

Answer: Slayback Pharma has 51-200 employees

Answer: Slayback Pharma is in Pharmaceuticals

Answer: Slayback Pharma contact info: Phone number: 60******** Website: https://slayback-pharma.com

Answer: Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback has created a unique portfolio of complex generics by smart product selection and execution and connecting various dots through a network of contract R&D laboratories and manufacturing organizations, comprising smart and rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access